Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
BMC Biology
|
April 28, 2006
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor
Michael Kraich, Markus Klein, Edwin Patiño, et al.
Journal of Bone and Mineral Metabolism
|
February 21, 2009
Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing
Koichi Yano, Masatoshi Hoshino, Yoichi Ohta, et al.
Investigative Ophthalmology & Visual Science
|
March 28, 2006
p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts
Tobias Meyer-Ter-Vehn, Susanne Gebhardt, Walter Sebald, et al.
Bone
|
July 4, 2012
L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin
Christoph E Albers, Wilhelm Hofstetter, Hans-Jörg Sebald, et al.
BMC Structural Biology
|
February 14, 2007
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor
Dionys Weber, Alexander Kotzsch, Joachim Nickel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 7, 2011
New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance
Gerburg K Schwaerzer, Christian Hiepen, Heinrich Schrewe, et al.
Proteomics
|
December 31, 2005
Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface
Wlad Kusnezow, Yana V Syagailo, Sven Rüffer, et al.
Bioconjugate Chemistry
|
December 18, 2013
IL-4 analogues with site-specific chemical modification at position 121 inhibit IL-4 and IL-13 biological activities
Viswanadham Duppatla, Maja Gjorgjevikj, Werner Schmitz, et al.
The Journal of Biological Chemistry
|
December 28, 2007
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome
Alexander Kotzsch, Joachim Nickel, Axel Seher, et al.
Clinical Oral Implants Research
|
September 2, 2009
Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles
João Paulo Mardegan Issa, Cássio do Nascimento, Teresa Lamano, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
BMC Biology
|
April 28, 2006
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor
Michael Kraich, Markus Klein, Edwin Patiño, et al.
Journal of Bone and Mineral Metabolism
|
February 21, 2009
Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing
Koichi Yano, Masatoshi Hoshino, Yoichi Ohta, et al.
Investigative Ophthalmology & Visual Science
|
March 28, 2006
p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts
Tobias Meyer-Ter-Vehn, Susanne Gebhardt, Walter Sebald, et al.
Bone
|
July 4, 2012
L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin
Christoph E Albers, Wilhelm Hofstetter, Hans-Jörg Sebald, et al.
BMC Structural Biology
|
February 14, 2007
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor
Dionys Weber, Alexander Kotzsch, Joachim Nickel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 7, 2011
New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance
Gerburg K Schwaerzer, Christian Hiepen, Heinrich Schrewe, et al.
Proteomics
|
December 31, 2005
Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface
Wlad Kusnezow, Yana V Syagailo, Sven Rüffer, et al.
Bioconjugate Chemistry
|
December 18, 2013
IL-4 analogues with site-specific chemical modification at position 121 inhibit IL-4 and IL-13 biological activities
Viswanadham Duppatla, Maja Gjorgjevikj, Werner Schmitz, et al.
The Journal of Biological Chemistry
|
December 28, 2007
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome
Alexander Kotzsch, Joachim Nickel, Axel Seher, et al.
Clinical Oral Implants Research
|
September 2, 2009
Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles
João Paulo Mardegan Issa, Cássio do Nascimento, Teresa Lamano, et al.
Page
of 8